First Trust Advisors’s Immunomedics Inc IMMU Stock Holding History

First Trust Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-368,852	Closed	-$31.4M	–	2474
2020 Q3	$31.4M	Buy	+368,852	New	+$18.7M	0.05%	432
2020 Q2	–	Sell	-129,776	Closed	-$1.75M	–	2506
2020 Q1	$1.75M	Buy	+129,776	New	+$2.18M	﹤0.01%	1336
2018 Q4	–	Sell	-137,465	Closed	-$2.86M	–	2515
2018 Q3	$2.86M	Buy	137,465 +110,913	+418%	+$2.63M	0.01%	1460
2018 Q2	$628K	Sell	26,552 -79,787	-75%	-$1.6M	﹤0.01%	2077
2018 Q1	$1.55M	Sell	106,339 -32,753	-24%	-$535K	﹤0.01%	1605
2017 Q4	$2.25M	Buy	+139,092	New	+$1.64M	0.01%	1453

First Trust Advisors's IMMU Position: Q4 2020 in Review

First Trust Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 368,852 shares — an estimated $31.4M sold.

First Trust Advisors first reported a position in IMMU in Q4 2017 and held it in 6 quarters. The position peaked at $31.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

First Trust Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
First Trust Advisors sold 368,852 Immunomedics Inc shares in Q4 2020, an estimated $31.4M.
First Trust Advisors first reported a position in Immunomedics Inc in Q4 2017 and held it in 6 quarters.
First Trust Advisors's Immunomedics Inc position peaked at $31.4M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on First Trust Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.